Capricor Therapeutics CAPR Business Segments — Investment Income Interest And Dividend
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Capricor Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterestAndDividend.
The official record: Capricor Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Capricor Therapeutics's business segments — investment income interest and dividend.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Capricor Therapeutics's business segments — investment income interest and dividend?
- Capricor Therapeutics (CAPR) reported business segments — investment income interest and dividend of $2.9M in Q1 2026.
- How has Capricor Therapeutics's business segments — investment income interest and dividend changed year-over-year?
- Capricor Therapeutics's business segments — investment income interest and dividend increased by 298.1% year-over-year, from $729.54K to $2.9M.
- What does business segments — investment income interest and dividend mean?
- This represents the income earned from the company's cash reserves, marketable securities, or other financial investments. It serves as a source of non-operating revenue that helps offset the high costs of clinical development. Monitoring this provides insight into the company's treasury management and liquidity strategy.